| 6.753 0 (0%) | 10-03 09:52 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Operating within the United States, NeueHealth, Inc. is a healthcare enterprise dedicated to delivering a diverse array of medical solutions to patients, care providers, and insurance entities. The company is structured into two primary divisions. Its NeueCare segment directly offers medical treatment to individuals enrolled in ACA marketplace, Medicare, and Medicaid plans. This is achieved through a network of both company-owned and partner clinics, which frequently operate under a risk-bearing model and include brands such as Centrum Health, AssociatesMD, and Premier Medical Associates. Beyond direct care, NeueCare also encompasses a comprehensive integrated system, featuring on-site pharmacy, laboratory, and radiology facilities, alongside specialized services focused on population health. Furthermore, it provides essential support for managing chronic conditions, coordinating patient transitions between care settings, and streamlining specialist referrals. The NeueSolutions segment, on the other hand, is designed to empower healthcare professionals and medical practices, assisting them in excelling within value-based care agreements. This division also actively works to enhance access to healthcare for Medicare beneficiaries. Established in 2015, the firm is based in Doral, Florida. It adopted the name NeueHealth, Inc. in January 2024, having previously operated as Bright Health Group, Inc.
Mon, 06 Oct 2025
NEA Closes $1.465B Deal to Take NeueHealth Private - citybiz
Fri, 03 Oct 2025
NeueHealth Closes $1.465B Acquisition by NEA and Investor Consortium - HLTH
Thu, 02 Oct 2025
NeueHealth announces closing of more than $1.4B acquisition - MobiHealthNews
Thu, 02 Oct 2025
NeueHealth officially goes private as $1.5B sale to New Enterprise Associates closes - Fierce Healthcare
Thu, 28 Aug 2025
NeueHealth's Mikan tops insurtech CEO pay list in 2024 - S&P Global
Thu, 08 May 2025
NeueHealth to go private after shareholder vote - Modern Healthcare
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |